International Patent: CHIMERIC T CELL RECEPTORS TARGETING BUTYROPHILIN-LIKE PROTEINS

GENEVA, Oct. 9 -- GENTIBIO, INC. filed a patent application (US2026/021796) for “CHIMERIC T CELL RECEPTORS TARGETING BUTYROPHILIN-LIKE PROTEINS”. With publication no. WO/2026/213230, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 5/0783

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....